Pipeline & growth

Where our pipeline is headed.

We build the pipeline around late-stage products with strong clinical profiles and unmet U.S. market demand. We extend our distribution infrastructure with the market access each product needs for commercialization, then launch through our established network of independent retail and specialty pharmacies, medical practices, and specialty wholesalers.

Partner with us What's on the market now

Launch schedule

Nine launches, three quarters.

Q3 2026

  • Lidocaine patch (PHN)
  • Anticonvulsant capsules

Q4 2026

  • SNRI capsules
  • Antibiotic tablets
  • NSAID capsules
  • PPI capsules

Q1 2027

  • LidoPro® Patch XR
  • NSAID solution
  • Lidocaine 5% ointment

Core pipeline grid

Focus areas and strategic goals.

Focus areaNear-term actionsStrategic goal
Pain & musculoskeletalLaunch NSAID, lidocaine, and other pain-relief patches and gels with partners in 2026Establish Terrain Rx as the preferred non-opioid pain platform
Adjunctive careProlaxa® stool-softener softgel launched internallySpecialty and dosage-form diversification
Controlled-release DIA techAdvance the next-generation delivery matrix with improved permeationEnable higher-strength Rx patches while reducing API load
Pipeline licensingAcquire select ANDAs and 505(b)(2) assetsAdd near-term revenue through existing channels
DistributionExpand wholesaler and prescriber network footprintImprove market visibility and speed product pull-through
Partnership capitalDeploy co-development funds with CMOs & brand ownersShare risk, speed scale-up, and secure demand for new capacity

The process

How we move ideas to market.

Evaluate

Technical & commercial due diligence, CQA mapping, pathway selection.

Execute

Formulation lock, tech transfer, regulatory filing, channel staging.

Expand

Line extensions, new packs, and channel deepening for lifecycle extension.

Growth or liquidity

Option for Terrain Rx to purchase the asset or buy out royalties on mature assets.

Partner touchpoints

Who brings what, at each stage.

StageIdeal partner contributionTerrain Rx contribution
Concept / asset reviewDossier, analytics, cost targetsMarket mapping, regulatory gap analysis
Development & scale-upAPI / tech package, facility accessFormulation IP, CMC, capital, validation support
Launch & growthField insights, demand signalsDistribution, reimbursement, performance reporting

Contact

Bring us an asset.

877 985 8377

info@terrainrx.com

  • Address
    3650 Mayberry Dr, Suite 101-2
    Reno, NV 89509
  • Hours
    Mon–Fri, 8:00 AM – 5:00 PM Pacific
    Closed weekends and major U.S. holidays
  • Quality
Start the conversation

Safety

Medical emergencies. Our products are not intended for emergency treatment. Call 911 or visit your nearest emergency room.

Adverse event reporting. Contact our Quality Department at qa@terrainrx.com, or report to FDA MedWatch at (800) FDA-1088.